TipRanks
Qiagen NV (QGEN)
NYSE:QGEN
US Market
QGEN
Qiagen
RESEARCH TOOLSreports
Want to see QGEN full AI Analyst Report?

Qiagen (QGEN) Stock Forecast & Price Target

456 Followers
See the Price Targets and Ratings of:

QGEN Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
6 Buy
7 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Qiagen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QGEN Stock 12 Month Forecast

Average Price Target

$48.29
▲(10.62% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is $48.29 with a high forecast of $55.00 and a low forecast of $40.00. The average price target represents a 10.62% change from the last price of $43.65.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"32":"$32","38":"$38","44":"$44","50":"$50","56":"$56"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$55.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":48.28701022222222,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$48.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[32,38,44,50,56],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.04,43.036923076923074,44.033846153846156,45.03076923076923,46.027692307692305,47.02461538461539,48.02153846153846,49.01846153846154,50.01538461538462,51.012307692307694,52.00923076923077,53.00615384615385,54.003076923076925,{"y":55,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.04,42.52053924786325,43.001078495726496,43.481617743589744,43.96215699145299,44.44269623931624,44.92323548717948,45.40377473504273,45.88431398290598,46.36485323076923,46.845392478632476,47.325931726495725,47.80647097435897,{"y":48.28701022222222,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,42.04,41.88307692307692,41.72615384615384,41.56923076923077,41.41230769230769,41.255384615384614,41.098461538461535,40.941538461538464,40.784615384615385,40.62769230769231,40.47076923076923,40.31384615384616,40.15692307692308,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.983,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.509,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.995,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.642,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.713,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.393,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.019,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.943,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.856,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.78,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.39,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.04,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$55.00Average Price Target$48.29Lowest Price Target$40.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Robert W. Baird Analyst forecast on QGEN
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$50→$52
Buy
19.13%
Upside
Reiterated
10/22/26
Qiagen price target raised to $52 from $50 at BairdQiagen price target raised to $52 from $50 at Baird
J.P. Morgan Analyst forecast on QGEN
Casey Woodring
J.P. Morgan
J.P. Morgan
$55→$52
Hold
19.13%
Upside
Downgraded
10/22/26
Qiagen (QGEN) was downgraded to a Hold Rating at J.P. Morgan
DZ BANK AG Analyst forecast on QGEN
Sven Olaf Kuerten
DZ BANK AG
DZ BANK AG
―
Hold
―
Downgraded
10/22/26
DZ BANK AG downgrades Qiagen (QGEN) to a Hold
Deutsche Bank Analyst forecast on QGEN
Jan Koch
Deutsche Bank
Deutsche Bank
―
Buy
―
Reiterated
10/22/26
Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (NASDAQ: IART), Elevance Health (NYSE: ELV) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on QGEN
Luke Sergott
Barclays
Barclays
$55
Buy
26.00%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Qiagen (NYSE: QGEN) and Teladoc (NYSE: TDOC)
UBS Analyst forecast on QGEN
Unknown Analyst
UBS
Not Ranked
UBS
$47→$48
Hold
9.97%
Upside
Assigned
10/19/26
UBS Releases a Hold Rating on Qiagen (QGEN)
Bank of America Securities Analyst forecast on QGEN
Lu Li
Bank of America Securities
Bank of America Securities
$49→$50
Buy
14.55%
Upside
Reiterated
10/09/26
Qiagen price target raised to $50 from $49 at BofAQiagen price target raised to $50 from $49 at BofA
Morgan Stanley Analyst forecast on QGEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$44.84→$47.08
Buy
7.87%
Upside
Reiterated
09/11/26
Qiagen price target raised to EUR 42 from EUR 40 at Morgan StanleyQiagen price target raised to EUR 42 from EUR 40 at Morgan Stanley
Berenberg Bank Analyst forecast on QGEN
Harry Gillis
Berenberg Bank
Berenberg Bank
$45.5
Hold
4.24%
Upside
Reiterated
09/10/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Monopar Therapeutics Inc (NASDAQ: MNPR)
William Blair Analyst forecast on QGEN
Matt Larew
William Blair
William Blair
―
Hold
―
Assigned
08/24/26
Qiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation
Stifel Nicolaus Analyst forecast on QGEN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$40
Hold
-8.36%
Downside
Reiterated
08/11/26
Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)
Citi Analyst forecast on QGEN
‏Brendan Digan‏
Citi
Citi
$38→$45
Hold
3.09%
Upside
Reiterated
08/10/26
Qiagen price target raised to $45 from $38 at CitiQiagen price target raised to $45 from $38 at Citi
Jefferies Analyst forecast on QGEN
Tycho Peterson
Jefferies
Jefferies
―
Buy
―
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Qiagen (NYSE: QGEN) and Coherus Biosciences (NASDAQ: CHRS)
TD Cowen Analyst forecast on QGEN
Daniel Brennan
TD Cowen
TD Cowen
$40→$44
Hold
0.80%
Upside
Reiterated
07/15/26
Qiagen price target raised to $44 from $40 at TD CowenQiagen price target raised to $44 from $40 at TD Cowen
Kepler Capital Analyst forecast on QGEN
Unknown Analyst
Kepler Capital
Not Ranked
Kepler Capital
$38.6
Hold
-11.57%
Downside
Initiated
06/25/26
Qiagen (QGEN) Gets a Hold from Kepler Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Robert W. Baird Analyst forecast on QGEN
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$50→$52
Buy
19.13%
Upside
Reiterated
10/22/26
Qiagen price target raised to $52 from $50 at BairdQiagen price target raised to $52 from $50 at Baird
J.P. Morgan Analyst forecast on QGEN
Casey Woodring
J.P. Morgan
J.P. Morgan
$55→$52
Hold
19.13%
Upside
Downgraded
10/22/26
Qiagen (QGEN) was downgraded to a Hold Rating at J.P. Morgan
DZ BANK AG Analyst forecast on QGEN
Sven Olaf Kuerten
DZ BANK AG
DZ BANK AG
―
Hold
―
Downgraded
10/22/26
DZ BANK AG downgrades Qiagen (QGEN) to a Hold
Deutsche Bank Analyst forecast on QGEN
Jan Koch
Deutsche Bank
Deutsche Bank
―
Buy
―
Reiterated
10/22/26
Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (NASDAQ: IART), Elevance Health (NYSE: ELV) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on QGEN
Luke Sergott
Barclays
Barclays
$55
Buy
26.00%
Upside
Reiterated
10/21/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Qiagen (NYSE: QGEN) and Teladoc (NYSE: TDOC)
UBS Analyst forecast on QGEN
Unknown Analyst
UBS
Not Ranked
UBS
$47→$48
Hold
9.97%
Upside
Assigned
10/19/26
UBS Releases a Hold Rating on Qiagen (QGEN)
Bank of America Securities Analyst forecast on QGEN
Lu Li
Bank of America Securities
Bank of America Securities
$49→$50
Buy
14.55%
Upside
Reiterated
10/09/26
Qiagen price target raised to $50 from $49 at BofAQiagen price target raised to $50 from $49 at BofA
Morgan Stanley Analyst forecast on QGEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$44.84→$47.08
Buy
7.87%
Upside
Reiterated
09/11/26
Qiagen price target raised to EUR 42 from EUR 40 at Morgan StanleyQiagen price target raised to EUR 42 from EUR 40 at Morgan Stanley
Berenberg Bank Analyst forecast on QGEN
Harry Gillis
Berenberg Bank
Berenberg Bank
$45.5
Hold
4.24%
Upside
Reiterated
09/10/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Monopar Therapeutics Inc (NASDAQ: MNPR)
William Blair Analyst forecast on QGEN
Matt Larew
William Blair
William Blair
―
Hold
―
Assigned
08/24/26
Qiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation
Stifel Nicolaus Analyst forecast on QGEN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$40
Hold
-8.36%
Downside
Reiterated
08/11/26
Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)
Citi Analyst forecast on QGEN
‏Brendan Digan‏
Citi
Citi
$38→$45
Hold
3.09%
Upside
Reiterated
08/10/26
Qiagen price target raised to $45 from $38 at CitiQiagen price target raised to $45 from $38 at Citi
Jefferies Analyst forecast on QGEN
Tycho Peterson
Jefferies
Jefferies
―
Buy
―
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), Qiagen (NYSE: QGEN) and Coherus Biosciences (NASDAQ: CHRS)
TD Cowen Analyst forecast on QGEN
Daniel Brennan
TD Cowen
TD Cowen
$40→$44
Hold
0.80%
Upside
Reiterated
07/15/26
Qiagen price target raised to $44 from $40 at TD CowenQiagen price target raised to $44 from $40 at TD Cowen
Kepler Capital Analyst forecast on QGEN
Unknown Analyst
Kepler Capital
Not Ranked
Kepler Capital
$38.6
Hold
-11.57%
Downside
Initiated
06/25/26
Qiagen (QGEN) Gets a Hold from Kepler Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

3 Months
Jan KochDeutsche Bank
Success Rate
8/11 ratings generated profit
73%
Average Return
+11.26%
Copying Jan Koch's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +11.26% per trade.
1 Year
Jan KochDeutsche Bank
Success Rate
11/11 ratings generated profit
100%
Average Return
+25.70%
Copying Jan Koch's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.70% per trade.
2 Years
Jan KochDeutsche Bank
Success Rate
11/11 ratings generated profit
100%
Average Return
+25.70%
Copying Jan Koch's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QGEN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
12
9
12
10
14
Hold
13
11
15
14
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
20
27
24
26
In the current month, QGEN has received 14 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. QGEN average Analyst price target in the past 3 months is 48.29.
Each month's total comprises the sum of three months' worth of ratings.

QGEN Financial Forecast

QGEN Earnings Forecast

Next quarter’s earnings estimate for QGEN is $0.63 with a range of $0.61 to $0.65. The previous quarter’s EPS was $0.62. QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for QGEN is $0.63 with a range of $0.61 to $0.65. The previous quarter’s EPS was $0.62. QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.

QGEN Sales Forecast

Next quarter’s sales forecast for QGEN is $538.61M with a range of $534.29M to $548.00M. The previous quarter’s sales results were $535.04M. QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.
Next quarter’s sales forecast for QGEN is $538.61M with a range of $534.29M to $548.00M. The previous quarter’s sales results were $535.04M. QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.

QGEN Stock Forecast FAQ

What is QGEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Qiagen NV’s 12-month average price target is 48.29.
    What is QGEN’s upside potential, based on the analysts’ average price target?
    Qiagen NV has 10.62% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is QGEN a Buy, Sell or Hold?
          Qiagen NV has a consensus rating of Moderate Buy which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Qiagen NV’s price target?
            The average price target for Qiagen NV is 48.29. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $55.00 ,the lowest forecast is $40.00. The average price target represents 10.62% Increase from the current price of $43.65.
              What do analysts say about Qiagen NV?
              Qiagen NV’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of QGEN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.